Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 540 composition records across product categories including Specialty occupational products, Laboratory supplies, Personal care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of ACACIA in our catalog (epa_cpdat).
Products
540
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 540 composition records across product categories including Specialty occupational products, Laboratory supplies, Personal care. EPA CPDat classifies this chemical for functional uses including Film former, Deodorizer, Adhesion/cohesion promoter.
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 280 mg
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: BUCCAL; Dosage form: TABLET; Potency: 9.1 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SUSPENSION; Potency: 1 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 64 mg
US
FDA
Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 108 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: NA
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 7386 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 121 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 156 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 30 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 34.4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 7 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 9.1 mg
US
FDA
FDA NDC lists this ingredient in 8 active drug products and 8 total products.
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.
US
USDA FoodData Central
Observed in 1 USDA branded foods including 1.75L Bloody Mary with Horseradish (MED).